Company profile: Altasciences
1.1 - Company Overview
Company description
- Provider of early phase contract research services for pharmaceutical and biotechnology companies, including preclinical safety testing; Phase I–II clinical pharmacology; bioanalysis from preclinical to Phase IV (LC-MS/MS and ligand binding assays); formulation, manufacturing, and analytical services; specialized renal and hepatic impairment studies via external partners; and cardiac safety assessment including QT prolongation evaluation.
Products and services
- Clinical Pharmacology: Conducts Phase I–II human studies, examining drug effects, dosing, and pharmacokinetics in humans across early clinical stages
- Bioanalysis: Supplies analytical services from preclinical through Phase IV, utilizing LC-MS/MS and ligand binding assays to support drug discovery and development across the pipeline
- Preclinical Safety Testing: Executes assessment of drug safety before clinical trials begin, focusing on toxicological effects in non-human subjects within preclinical programs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Altasciences
Nutra-Med Packaging
HQ: United States
Website
- Description: Provider of supply chain management and contract packaging for pharmaceutical and healthcare products, offering blister packaging (thermoforming, cold forming, barcode printing), high-speed bottling (glass vials/bottles, labeling, gummy vitamins, serialization/aggregation), secondary assembly and kitting, cartoning, serialization for bottles, blisters and cartons, and cold chain storage with 80 pallet locations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nutra-Med Packaging company profile →
Cellipont
HQ: United States
Website
- Description: Provider of cell therapy CDMO services specializing in cell therapy development and small-to-large batch production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellipont company profile →
S-Cubed
HQ: Denmark
Website
- Description: Provider of consultancy services, including biometrics, biostatistics, data, and visual analytics for pharmaceutical industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full S-Cubed company profile →
Colorcon
HQ: United States
Website
- Description: Provider of specialty excipients, film coatings (immediate, enteric, sustained release), and functional packaging for solid oral dosage forms in pharmaceutical, nutritional, and animal health markets. Provides formulation support to enhance adherence, reduce medication errors, and add brand value. Products include Opadry, Acryl-EZE, Surelease, Starch 1500, METHOCEL, and StarTab, plus label-friendly solutions for dietary supplements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Colorcon company profile →
Adare Pharma Solutions
HQ: United States
Website
- Description: Provider of global technology-driven CDMO services spanning research, business and product development, formulation development (taste masking, customized release, patient-centered dosage forms), analytical services, clinical trial materials manufacturing and packaging (GMP and Non-GMP), commercial manufacturing, packaging, and logistical support, with delivery technologies including Diffucaps®, Microcaps®, and Optimμm®.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adare Pharma Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Altasciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Altasciences
2.2 - Growth funds investing in similar companies to Altasciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Altasciences
4.2 - Public trading comparable groups for Altasciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →